NASDAQ: SCNI
Scinai Immunotherapeutics Ltd Stock Ownership - Who owns Scinai Immunotherapeutics?

Insider buying vs selling

Have Scinai Immunotherapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SCNI insiders and whales buy or sell their stock.

SCNI Shareholders

What type of owners hold Scinai Immunotherapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Amir Reichman2.25%311,637,600$222.51MInsider
Elad Mark1.16%160,355,016$114.49MInsider
URI Benor0.24%33,329,004$23.80MInsider
George Lowell0.00%421,680$301.08kInsider
Yael Margolin0.00%66,800$47.70kInsider
Avner Rotman0.00%66,800$47.70kInsider
Adi Raviv0.00%66,800$47.70kInsider
Morris C. Laster0.00%66,800$47.70kInsider
Citadel Advisors LLC0.00%34,562$24.68kInstitution
Xtx Topco Ltd0.00%27,294$19.49kInstitution

1 of 2

SCNI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SCNI0.00%3.65%
NCNA0.00%0.01%
BDRX0.00%0.00%
ELAB0.02%99.98%
ADTX1.19%98.81%Net BuyingNet Buying

Scinai Immunotherapeutics Stock Ownership FAQ

Who owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics (NASDAQ: SCNI) is owned by 0.00% institutional shareholders, 3.65% Scinai Immunotherapeutics insiders, and 96.35% retail investors. Amir Reichman is the largest individual Scinai Immunotherapeutics shareholder, owning 311.64M shares representing 2.25% of the company. Amir Reichman's Scinai Immunotherapeutics shares are currently valued at $230.61M.

If you're new to stock investing, here's how to buy Scinai Immunotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.